Last month, Alliance for Cancer Gene Therapy held its first in-person, day-long scientific gathering to bring together top scientists in the field of cancer cell and gene therapy. ACGT Summit 2023 was an invitation-only event that featured ACGT Research Fellows, ACGT Scientific Advisory Council members, biotech leaders, and other thought-leaders.
A curated agenda of speakers allowed the scientists to share ideas among their peers to help advance cell and gene therapy research and development – ultimately, to benefit patients diagnosed with difficult-to-treat cancers, especially those with solid tumors.
“The talent that was here was amazing,” said ACGT Research Fellow Brian Brown, PhD, of Icahn School of Medicine at Mount Sinai. “There were people who I looked up to my entire career. It was an intimate environment. The way they structured the event where it was light on presenting the science and heavy on conversation and interaction, it’s a great forum. ACGT is great.”
The ACGT Summit 2023 was viewed by everyone in attendance as a much-needed event, especially after three years without in-person gatherings due to the COVID-19 pandemic.
“This feels like being back to normal finally. It helps the science. It helps the exchange of ideas and collaboration,” said ACGT Research Fellow and Scientific Advisory Council member E. Antonio Chiocca, MD, PhD, of Brigham and Women’s Hospital.
Everyone who attended the summit is committed to uncovering cures for cancer through cell and gene therapy science. It is thanks to ACGT that many of these scientists have funding to conduct crucial research. Please go to our site to donate and support these experts as they continue to research ways to empower our immune system to fight cancer.